100 related articles for article (PubMed ID: 3398646)
1. Adaptive changes in the effects of angiotensin II on the convulsive-seizure threshold in cases of altered sensitivity of dopamine receptors.
Georgiev V; Petkova B; Kambourova T
Methods Find Exp Clin Pharmacol; 1988 May; 10(5):295-9. PubMed ID: 3398646
[TBL] [Abstract][Full Text] [Related]
2. Involvement of transmitter mechanisms in the behavioural effects of angiotensin II.
Georgiev V
Pol J Pharmacol Pharm; 1990; 42(6):553-62. PubMed ID: 1983291
[TBL] [Abstract][Full Text] [Related]
3. Interactions of angiotensin II with piracetam in exploratory behavior and convulsive-seizure threshold.
Georgiev V; Petkova B; Kambourova T; Opitz M
Acta Physiol Pharmacol Bulg; 1989; 15(1):70-5. PubMed ID: 2773651
[TBL] [Abstract][Full Text] [Related]
4. Brain dopamine and seizure susceptibility in mice.
Kleinrok Z; Czuczwar S; Wójcik A; Przegaliński E
Pol J Pharmacol Pharm; 1978; 30(4):513-9. PubMed ID: 740553
[TBL] [Abstract][Full Text] [Related]
5. Ang II and Ang III modulate PTZ seizure threshold in non-stressed and stressed mice: possible involvement of noradrenergic mechanism.
Tchekalarova J; Georgiev V
Neuropeptides; 2006 Oct; 40(5):339-48. PubMed ID: 17045647
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic influence on the effects of angiotensin II in behavioural reactions.
Georgiev V; György L; Yonkov D; Getova D; Markovska V; Petkova B
Physiol Bohemoslov; 1985; 34 Suppl():45-8. PubMed ID: 3014581
[TBL] [Abstract][Full Text] [Related]
7. Interactions of angiotensin II and GABA-ergic agents at the threshold of convulsive reactions.
Georgiev VP; Petkova BP; Petkov VD; Kambourova TS
Acta Physiol Pharmacol Bulg; 1986; 12(2):14-20. PubMed ID: 3020873
[TBL] [Abstract][Full Text] [Related]
8. Are the central dopaminergic synapses related to the convulsive-seizure threshold?--Effects of central dopaminergic drugs on the picrotoxin convulsive-seizure threshold. Interaction with diazepam, meta-tolylcarbamide and theophylline.
Markovska VL; Georgiev VP
Acta Physiol Pharmacol Bulg; 1976; 2(4):59-65. PubMed ID: 1029380
[No Abstract] [Full Text] [Related]
9. Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: possible involvement of adenosinergic mechanism.
Akula KK; Dhir A; Kulkarni SK
Epilepsy Res; 2008 Jan; 78(1):60-70. PubMed ID: 18054463
[TBL] [Abstract][Full Text] [Related]
10. Some central effects of angiotensin II. Interactions with dopaminergic transmission.
Georgiev V; György L; Getova D; Markovska V
Acta Physiol Pharmacol Bulg; 1985; 11(4):19-26. PubMed ID: 3012944
[TBL] [Abstract][Full Text] [Related]
11. Effects of [arginine8, glycine-OH9]-vasopressin on pentylenetetrazol seizures in mice. Interaction with adrenaline.
Lambadjieva ND; Georgiev VP; Kambourova TS
Methods Find Exp Clin Pharmacol; 1997 Apr; 19(3):161-6. PubMed ID: 9203163
[TBL] [Abstract][Full Text] [Related]
12. Comparative studies on the central effects of the angiotensin II analogue (Sar1 azaVal3 Ile8) AT II.
Georgiev VP; Klusha VE; Getova DP; Petkov VD; Svirskis SV; Mutsenietse RK; Kambourova TS; Oppitz MZh; Ancans JE
Acta Physiol Pharmacol Bulg; 1988; 14(1):22-9. PubMed ID: 3407412
[TBL] [Abstract][Full Text] [Related]
13. On some relationships between dopaminergic and serotoninergic mechanisms in pentylenetetrazol convulsions in albino mice.
Lazarova M; Roussinov K
Acta Physiol Pharmacol Bulg; 1979; 5(3):67-74. PubMed ID: 317212
[TBL] [Abstract][Full Text] [Related]
14. Behavioural effects of angiotensin II in the mouse following MPTP administration.
Georgiev V; Kambourova T
Gen Pharmacol; 1991; 22(4):625-30. PubMed ID: 1657686
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of dopamine D1 and D2 receptors in the basal ganglia of PTZ kindling model of epilepsy: effects of angiotensin IV.
Tchekalarova J; Sotiriou E; Angelatou F
Brain Res; 2004 Oct; 1024(1-2):159-66. PubMed ID: 15451378
[TBL] [Abstract][Full Text] [Related]
16. Central effects of angiotensin II, its fragment and analogues.
Georgiev VP; Klousha VE; Petkov VD; Markovska VL; Svirskis SV; Mountsinietse RK; Anouans ZE
Acta Physiol Pharmacol Bulg; 1984; 10(4):36-43. PubMed ID: 6085530
[TBL] [Abstract][Full Text] [Related]
17. Effect of systemic administration of adenosine on brain adenosine levels in pentylenetetrazol-induced seizure threshold in mice.
Akula KK; Dhir A; Bishnoi M; Kulkarni SK
Neurosci Lett; 2007 Sep; 425(1):39-42. PubMed ID: 17720312
[TBL] [Abstract][Full Text] [Related]
18. Effects of apomorphine and piribedil on pentylenetetrazol-induced seizures in mice.
Riffee WH; Wilcox RE; Goldman CP; Smith RV
Psychopharmacology (Berl); 1981; 75(4):391-5. PubMed ID: 6803286
[TBL] [Abstract][Full Text] [Related]
19. Seizure susceptibility alteration following reversible cholestasis in mice: Modulation by opioids and nitric oxide.
Gholipour T; Riazi K; Noorian AR; Jannati A; Honar H; Doratotaj B; Nik HH; Shariftabrizi A; Dehpour AR
Eur J Pharmacol; 2008 Feb; 580(3):322-8. PubMed ID: 18164287
[TBL] [Abstract][Full Text] [Related]
20. On certain effects of dopaminergic agents in pentylenetetrazol convulsions.
Lazarova MB; Roussinov KS
Acta Physiol Pharmacol Bulg; 1978; 4(3):50-5. PubMed ID: 751452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
